These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30495920)

  • 1. Smart Bacterial Magnetic Nanoparticles for Tumor-Targeting Magnetic Resonance Imaging of HER2-Positive Breast Cancers.
    Zhang Y; Ni Q; Xu C; Wan B; Geng Y; Zheng G; Yang Z; Tao J; Zhao Y; Wen J; Zhang J; Wang S; Tang Y; Li Y; Zhang Q; Liu L; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3654-3665. PubMed ID: 30495920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fe
    Yin Q; Gao X; Zhang H; Zhang Z; Yu X; He J; Shi G; Hao L
    Biomed Mater; 2024 Apr; 19(3):. PubMed ID: 38626777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide.
    Xiang Z; Yang X; Xu J; Lai W; Wang Z; Hu Z; Tian J; Geng L; Fang Q
    Biomaterials; 2017 Jan; 115():53-64. PubMed ID: 27888699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
    Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
    Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.
    Li DL; Tan JE; Tian Y; Huang S; Sun PH; Wang M; Han YJ; Li HS; Wu HB; Zhang XM; Xu YK; Wang QS
    Biomaterials; 2017 Dec; 147():86-98. PubMed ID: 28938164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetosomes, biogenic magnetic nanomaterials for brain molecular imaging with 17.2 T MRI scanner.
    Mériaux S; Boucher M; Marty B; Lalatonne Y; Prévéral S; Motte L; Lefèvre CT; Geffroy F; Lethimonnier F; Péan M; Garcia D; Adryanczyk-Perrier G; Pignol D; Ginet N
    Adv Healthc Mater; 2015 May; 4(7):1076-83. PubMed ID: 25676134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
    Alric C; Hervé-Aubert K; Aubrey N; Melouk S; Lajoie L; Même W; Même S; Courbebaisse Y; Ignatova AA; Feofanov AV; Chourpa I; Allard-Vannier E
    J Nanobiotechnology; 2018 Feb; 16(1):18. PubMed ID: 29466990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
    Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
    J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.
    Adolphi NL; Butler KS; Lovato DM; Tessier TE; Trujillo JE; Hathaway HJ; Fegan DL; Monson TC; Stevens TE; Huber DL; Ramu J; Milne ML; Altobelli SA; Bryant HC; Larson RS; Flynn ER
    Contrast Media Mol Imaging; 2012; 7(3):308-19. PubMed ID: 22539401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer.
    Jin YH; Hua QF; Zheng JJ; Ma XH; Chen TX; Zhang S; Chen B; Dai Q; Zhang XH
    Cell Physiol Biochem; 2018; 49(1):271-281. PubMed ID: 30138940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
    Sano K
    Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR and mammographic imaging features of HER2-positive breast cancers according to hormone receptor status: a retrospective comparative study.
    Song SE; Bae MS; Chang JM; Cho N; Ryu HS; Moon WK
    Acta Radiol; 2017 Jul; 58(7):792-799. PubMed ID: 27754920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
    Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.
    Ahlgren S; Orlova A; Wållberg H; Hansson M; Sandström M; Lewsley R; Wennborg A; Abrahmsén L; Tolmachev V; Feldwisch J
    J Nucl Med; 2010 Jul; 51(7):1131-8. PubMed ID: 20554729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized Magnetic PLGA Nanospheres for Targeting and Bioimaging of Breast Cancer.
    Lee SJ; Kim HJ; Huh YM; Kim IW; Jeong JH; Kim JC; Kim JD
    J Nanosci Nanotechnol; 2018 Mar; 18(3):1542-1547. PubMed ID: 29448628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and
    Okarvi SM; Aljammaz I
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging.
    Schuerle S; Furubayashi M; Soleimany AP; Gwisai T; Huang W; Voigt C; Bhatia SN
    ACS Synth Biol; 2020 Feb; 9(2):392-401. PubMed ID: 31922737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes.
    Ma S; Gu C; Xu J; He J; Li S; Zheng H; Pang B; Wen Y; Fang Q; Liu W; Tian J
    Int J Nanomedicine; 2022; 17():665-680. PubMed ID: 35185331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.